Bavarian Nordic A/S (BVNRY)
11.04
+0.17
(+1.56%)
USD |
OTCM |
Aug 24, 16:00
Bavarian Nordic Shareholders Equity (Quarterly) : 2.022B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.022B |
| March 31, 2026 | 1.956B |
| December 31, 2025 | 2.024B |
| September 30, 2025 | 2.071B |
| June 30, 2025 | 1.896B |
| March 31, 2025 | 1.673B |
| December 31, 2024 | 1.584B |
| September 30, 2024 | 1.600B |
| June 30, 2024 | 1.500B |
| March 31, 2024 | 1.473B |
| December 31, 2023 | 1.532B |
| September 30, 2023 | 1.326B |
| June 30, 2023 | 1.419B |
| March 31, 2023 | 1.330B |
| December 31, 2022 | 1.026B |
| September 30, 2022 | 916.72M |
| June 30, 2022 | 967.07M |
| March 31, 2022 | 1.066B |
| December 31, 2021 | 1.128B |
| September 30, 2021 | 899.41M |
| June 30, 2021 | 923.13M |
| March 31, 2021 | 935.65M |
| December 31, 2020 | 804.53M |
| September 30, 2020 | 829.29M |
| June 30, 2020 | 791.32M |
| Date | Value |
|---|---|
| March 31, 2020 | 751.46M |
| December 31, 2019 | 280.22M |
| September 30, 2019 | 276.28M |
| June 30, 2019 | 303.11M |
| March 31, 2019 | 313.92M |
| December 31, 2018 | 334.04M |
| September 30, 2018 | 354.89M |
| June 30, 2018 | 352.56M |
| March 31, 2018 | 384.94M |
| December 31, 2017 | 404.22M |
| September 30, 2017 | 418.98M |
| June 30, 2017 | 325.61M |
| March 31, 2017 | 293.38M |
| December 31, 2016 | 286.15M |
| September 30, 2016 | 288.95M |
| June 30, 2016 | 269.45M |
| March 31, 2016 | 185.45M |
| December 31, 2015 | 195.42M |
| September 30, 2015 | 194.91M |
| June 30, 2015 | 201.45M |
| March 31, 2015 | 182.42M |
| December 31, 2014 | 203.47M |
| September 30, 2014 | 149.59M |
| June 30, 2014 | 169.87M |
| March 31, 2014 | 180.67M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Evaxion AS | 9.531M |
| Genmab A/S | 5.957B |
| Ascendis Pharma A/S | 1.642B |
| Zealand Pharma A/S | 2.753B |
| Agenus, Inc. | -199.08M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.252B |
| Total Liabilities (Quarterly) | 230.26M |
| Debt to Equity Ratio | 0.0099 |
| Current Ratio | 6.532 |
| Net Debt Paydown Yield | -0.03% |